The three resistant substitutions map near one another in the folded actin monomer, near the protein binding site for the nucleotide. This cluster identifies a candidate region involved in drug recognition or in the conformational response to binding. Neighbouring residues in three-dimensional structure can help form a pocket even when they are not adjacent in the protein primary structure. Reduced drug binding at this region would connect the structural map to the resistant phenotype.
The map does not show a bound ToxB molecule. Substitutions could act indirectly by changing folding, nucleotide exchange or the assembly-competent conformation. Proximity to ATP does not prove competition for the ATP-binding site, and the mutant's abnormal baseline actin polymerization makes an allosteric explanation particularly relevant. Direct binding measurements on comparably folded wild-type and mutant actin monomers, together with nucleotide-binding controls and a ligand-bound structure, would distinguish these models. The allele/residue labels are interpreted as defined in this paper; no identification of their original experimental sequence substitutions is required.
Articles by others on the same topic
There are currently no matching articles.